Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,446,203
  • Shares Outstanding, K 31,611
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 154 M
  • EBITDA $ 321 M
  • 60-Month Beta 0.64
  • Price/Sales 2.31
  • Price/Cash Flow 3.66
  • Price/Book 5.18

Options Overview Details

View History
  • Implied Volatility 49.75% (-11.30%)
  • Historical Volatility 30.12%
  • IV Percentile 28%
  • IV Rank 33.95%
  • IV High 81.84% on 10/06/25
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 22) 4.67 (10.55%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 396
  • Open Int (30-Day) 401
  • Expected Range 39.55 to 48.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.01
  • Number of Estimates 3
  • High Estimate 2.08
  • Low Estimate 1.96
  • Prior Year 1.63
  • Growth Rate Est. (year over year) +23.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.00 +7.85%
on 02/26/26
49.31 -10.32%
on 02/05/26
-1.60 (-3.49%)
since 01/26/26
3-Month
41.00 +7.85%
on 02/26/26
50.79 -12.93%
on 12/29/25
-2.01 (-4.35%)
since 11/26/25
52-Week
23.23 +90.36%
on 04/10/25
50.79 -12.93%
on 12/29/25
+15.87 (+55.98%)
since 02/26/25

Most Recent Stories

More News
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 44.22 (-3.34%)
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

COLL : 44.22 (-3.34%)
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

– Generated Quarterly Net Revenues of $205.4 Million, Up 13% Year-over-Year, and Record Full-Year Net Revenues of $780.6 Million, Up 24% Year-over-Year – – Generated Record Quarterly and Full-Year...

COLL : 44.22 (-3.34%)
Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect

Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect

COLL : 44.22 (-3.34%)
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Boston Legacy FC today announced a multi-year partnership with Collegium Pharmaceutical , an emerging biopharmaceutical leader in the Boston area, naming...

COLL : 44.22 (-3.34%)
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

STOUGHTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2025 financial results before the...

COLL : 44.22 (-3.34%)
1 Profitable Stock on Our Watchlist and 2 That Underwhelm

1 Profitable Stock on Our Watchlist and 2 That Underwhelm

CHE : 396.63 (-15.00%)
COLL : 44.22 (-3.34%)
TOST : 27.75 (+3.51%)
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product,...

COLL : 44.22 (-3.34%)
3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

COLL : 44.22 (-3.34%)
GES : 16.81 (-0.30%)
TKR : 109.88 (+2.03%)
Collegium Provides 2026 Financial Guidance and Business Update

– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM ® Net Revenue Expected in the Range of $190 Million to $200 Million – – Adjusted EBITDA*...

COLL : 44.22 (-3.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 50.11
2nd Resistance Point 47.65
1st Resistance Point 45.93
Last Price 44.22
1st Support Level 41.75
2nd Support Level 39.29
3rd Support Level 37.57

See More

52-Week High 50.79
Last Price 44.22
Fibonacci 61.8% 40.26
Fibonacci 50% 37.01
Fibonacci 38.2% 33.76
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar